Collegeville, PA, United States of America

Jae U Jeong

This inventor holds 9 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: Glaxosmithkline Intellectual Property Development Limited, Smithkline Beecham Corporation. Active years: 2006-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae U Jeong. Retrieved from https://idiyas.com/inventor/jae-u-jeong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9 

% Patents Active = 88.9

 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2006-2022

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Inventor Jae U Jeong - Pioneering Innovations in Collegeville

Introduction: Jae U Jeong is a visionary inventor based in Collegeville, PA, known for her groundbreaking contributions to the field of technology and beyond.

Latest Patents: Jae U Jeong holds several patents in the areas of artificial intelligence, renewable energy, and sustainable materials, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Jae U Jeong has worked with leading research institutions and tech companies, consistently pushing the boundaries of innovation.

Collaborations: Throughout her career, Jae U Jeong has collaborated with top scientists, engineers, and designers, fostering a culture of creativity and excellence in all her projects.

Conclusion: Jae U Jeong's passion for innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and creators worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…